Table 1.
Baseline characteristics of the study group.
| Variables | Patients (104) |
|---|---|
| Gender (male)a | 53 (51) |
| Age at baseline, yearsb | 64.8 ± 15 |
| CKD etiologya | |
| Glomerulonephritis | 22 (21.2) |
| Hypertension/vascular | 22 (21.2) |
| Diabetes | 21 (20.2) |
| Tubulointersticial nephritis | 8 (7.7) |
| ADPKD | 5 (4.8) |
| Unknown | 3 (2.9) |
| Hypertensiona | 79 (76) |
| Diabetesa | 31 (29.8) |
| Dyslipidemiaa | 54 (51.9) |
| History of cardiovascular diseasea | 62 (59.6) |
| History of peripheral vascular diseasea | 26 (25) |
| History of cancera | 28 (26.9) |
| History of kidney transplantationa | 32 (30.8) |
| Charlson indexb | 6.5 ± 2.8 |
| Hepatitis Ca | 23 (22.1) |
| Central venous cathetera | 56 (53.8) |
| Hemodiafiltrationa | 46 (44.2) |
| Time on hemodialysis, monthsc | 34 (8–83) |
| Kt/Vb | 1.6 ± 0.3 |
| Hemoglobin, g/dLb | 11.8 ± 1.3 |
| Albumin, g/dLb | 3.9 ± 0.4 |
| Calcium, mg/dLb | 9.1 ± 0.6 |
| Phosphorus, mg/dLb | 4.8 ± 1.6 |
| PTH, pg/mLc | 226 (149–440) |
| C Reactive Protein, mg/dLc | 0.8 (0.4–1.8) |
an (%).
bMean ± SD.
cMedian (interquartile range).
ADPKD, autosomal dominant polycystic kidney disease; PTH, parathormona; CKD, chronic kidney disease.